Alyeska Investment Group L.P. Sells 400,000 Shares of ASP Isotopes Inc. (NASDAQ:ASPI)

Alyeska Investment Group L.P. reduced its stake in shares of ASP Isotopes Inc. (NASDAQ:ASPI) by 53.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 347,022 shares of the company’s stock after selling 400,000 shares during the quarter. Alyeska Investment Group L.P.’s holdings in ASP Isotopes were worth $1,572,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Hanson & Doremus Investment Management purchased a new position in shares of ASP Isotopes during the fourth quarter valued at about $27,000. B. Riley Wealth Advisors Inc. purchased a new position in shares of ASP Isotopes during the 3rd quarter worth approximately $42,000. Avantax Advisory Services Inc. bought a new position in shares of ASP Isotopes in the 4th quarter worth approximately $45,000. Russell Investments Group Ltd. lifted its stake in shares of ASP Isotopes by 56.3% in the 4th quarter. Russell Investments Group Ltd. now owns 10,221 shares of the company’s stock valued at $46,000 after purchasing an additional 3,682 shares during the period. Finally, SVB Wealth LLC bought a new stake in shares of ASP Isotopes during the fourth quarter valued at approximately $49,000. 16.80% of the stock is owned by hedge funds and other institutional investors.

ASP Isotopes Trading Up 1.0 %

Shares of NASDAQ ASPI opened at $5.50 on Wednesday. The stock has a market cap of $413.14 million, a P/E ratio of -9.02 and a beta of 3.40. The company has a debt-to-equity ratio of 0.80, a current ratio of 7.55 and a quick ratio of 7.54. ASP Isotopes Inc. has a 1 year low of $1.86 and a 1 year high of $9.33. The firm has a 50-day moving average of $4.86 and a 200 day moving average of $5.38.

Insider Transactions at ASP Isotopes

In other news, COO Robert Ainscow sold 66,668 shares of ASP Isotopes stock in a transaction dated Thursday, April 17th. The stock was sold at an average price of $5.62, for a total value of $374,674.16. Following the completion of the transaction, the chief operating officer now owns 1,419,992 shares of the company’s stock, valued at $7,980,355.04. The trade was a 4.48 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Paul Elliot Mann sold 316,667 shares of the stock in a transaction dated Tuesday, April 15th. The shares were sold at an average price of $5.75, for a total transaction of $1,820,835.25. Following the sale, the chief executive officer now directly owns 7,948,787 shares in the company, valued at $45,705,525.25. This trade represents a 3.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 766,667 shares of company stock valued at $4,358,502 in the last ninety days. 21.40% of the stock is currently owned by corporate insiders.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.